After DEA’s of its draft temporary rule last week, the Drug Enforcement Administration (“DEA”) has officially published a temporary rule expanding COVID-19 related flexibilities for prescribing controlled substances via telehealth. The... Read More
Beginning in March 2020 with the shutdown orders effectuated by Governor Phil Murphy, the various licensing boards organized under the State of New Jersey, Division of Consumer Affairs, experienced a significant decrease in activity. The state was... Read More
Last month, HHS Office for Civil Rights (“OCR”) announced that its COVID-19 related enforcement discretion regarding the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) will end on May 11, 2023, coinciding with the... Read More
While the survival and enforceability of noncompete agreements remain uncertain, those that exist are still being challenged, and courts are scrutinizing the language contained therein. Courts have routinely enforced noncompete agreements that were... Read More
Frier Levitt Partner Guillermo Beades and Jim Tudor, Director of Coding & Billing Compliance at HealthCare Compliance Network, recently had the opportunity to contribute their insights and expertise on medical payer audits to the American Health... Read More
The Federal Trade Commission (“FTC”) recently enforced its Health Breach Notification Rule (“Rule”) for the very first time. The FTC issued a $1.5 million civil penalty to GoodRx and imposed restrictions on the company’s future handling of... Read More
On Friday, February 24, 2023, the Drug Enforcement Agency (“DEA”) issued long awaited proposed rules for prescribing controlled substances via telehealth after the conclusion of the COVID-19 Public Health Emergency (“PHE”). The Controlled... Read More
A motion to dismiss that has been pending since last year was recently decided in the matter of U.S. ex rel. Teresa Ross v. Independent Health Association, et al. The decision may very well be a bellwether for future Medicare Advantage (“MA”)... Read More
Medical providers have long been subject to regular audits by public and private payers. However, with the outbreak of the COIVD-19 pandemic and the resulting high expenses for COVID-19-related testing and treatment, there has been an increase in... Read More
A staple of Medicare and False Claims Act (“FCA”) law – the so-called “Overpayment Rule” – may soon be undergoing a dramatic shift, and doing so in a way that could increase liability for healthcare providers while potentially reducing... Read More